An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
CONCLUSION: Combined RNAi of CTTN and FGF2 may be a novel and promising intervention strategy for HCC invasion and metastasis.PMID:38031266 | DOI:10.2174/0115680096254722231025110912 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: Jiaming Zhou Jiaxuan Liu Tiejun Li Qiang Zhong Hongyu Yu Source Type: research

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
CONCLUSION: Combined RNAi of CTTN and FGF2 may be a novel and promising intervention strategy for HCC invasion and metastasis.PMID:38031266 | DOI:10.2174/0115680096254722231025110912 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: Jiaming Zhou Jiaxuan Liu Tiejun Li Qiang Zhong Hongyu Yu Source Type: research

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
CONCLUSION: Combined RNAi of CTTN and FGF2 may be a novel and promising intervention strategy for HCC invasion and metastasis.PMID:38031266 | DOI:10.2174/0115680096254722231025110912 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: Jiaming Zhou Jiaxuan Liu Tiejun Li Qiang Zhong Hongyu Yu Source Type: research

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
CONCLUSION: Combined RNAi of CTTN and FGF2 may be a novel and promising intervention strategy for HCC invasion and metastasis.PMID:38031266 | DOI:10.2174/0115680096254722231025110912 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: Jiaming Zhou Jiaxuan Liu Tiejun Li Qiang Zhong Hongyu Yu Source Type: research

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
CONCLUSION: Combined RNAi of CTTN and FGF2 may be a novel and promising intervention strategy for HCC invasion and metastasis.PMID:38031266 | DOI:10.2174/0115680096254722231025110912 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: Jiaming Zhou Jiaxuan Liu Tiejun Li Qiang Zhong Hongyu Yu Source Type: research

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
CONCLUSION: Combined RNAi of CTTN and FGF2 may be a novel and promising intervention strategy for HCC invasion and metastasis.PMID:38031266 | DOI:10.2174/0115680096254722231025110912 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: Jiaming Zhou Jiaxuan Liu Tiejun Li Qiang Zhong Hongyu Yu Source Type: research

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research

Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
CONCLUSION: Combined RNAi of CTTN and FGF2 may be a novel and promising intervention strategy for HCC invasion and metastasis.PMID:38031266 | DOI:10.2174/0115680096254722231025110912 (Source: Current Cancer Drug Targets)
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: Jiaming Zhou Jiaxuan Liu Tiejun Li Qiang Zhong Hongyu Yu Source Type: research

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer
Curr Cancer Drug Targets. 2023 Nov 29. doi: 10.2174/0115680096270555231113074003. Online ahead of print.ABSTRACTColorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the dia...
Source: Current Cancer Drug Targets - November 30, 2023 Category: Cancer & Oncology Authors: N R Shruthi M K Makalakshmi Alakesh Das Antara Banerjee Suhanya Veronica Alexander Sun-Zhang Hong Zhang Muralidharan Anbalagan Xiao-Feng Sun Surajit Pathak Source Type: research